Theratechnologies  logo
Theratechnologies THTX
$ 1.2 0.0%

Annual report 2023
added 10-19-2024

report update icon

Theratechnologies Balance Sheet 2011-2024 | THTX

Annual Balance Sheet Theratechnologies

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- 40.1 M 26.6 M 10.2 M 6.74 M 9.26 M 2.28 M 13.3 M -900 K -1.5 M -2.5 M

Long Term Debt

- - - 52.4 M 55.3 M 49.2 M 3.36 M 6.59 M 9.26 M 10.1 M - - -

Long Term Debt Current

421 K 476 K 463 K 425 K - - - - - - - - -

Total Non Current Liabilities

- - - 55 M 55.6 M 49.2 M 3.36 M 7.88 M 9.78 M 10.1 M 1.6 M 7.3 M 4.9 M

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

98.6 M 116 M 101 M 96.9 M 2.95 M 76.1 M 24.6 M 19.3 M 22.3 M 18.6 M 6 M 13.7 M 16.2 M

Deferred Revenue

- - - 50 K - - - - - - - - -

Retained Earnings

- - - -300 M -277 M -265 M -223 M -208 M -208 M -211 M -255 M -268 M -248 M

Total Assets

77.8 M 93.3 M 119 M 100 M 2.95 M 111 M 56.5 M 39.2 M 37.1 M 24.5 M 23.4 M 36.5 M 51.9 M

Cash and Cash Equivalents

34.1 M 23.9 M 20.4 M 12.7 M 28.7 M 39 M - - - - - - -

Book Value

-20.9 M -22.6 M 17.8 M 3.22 M - 35 M 31.9 M 19.9 M 14.8 M 5.91 M 17.4 M 22.8 M 35.7 M

Total Shareholders Equity

- - - 3.22 M 24.8 M 35 M 33.4 M - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Theratechnologies

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 2.06 M - - - 2.56 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 56.4 M - - - 55 M - - - 55.6 M - - - 49.2 M - - - 3.52 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 101 M - - - 96.9 M - - - 2.95 M - - - 76.1 M - - - 25.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -335 M - - - -300 M - - - - - - - -265 M - - - -261 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 119 M - - - 100 M - - - 2.95 M - - - 111 M - - - 59.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 20.4 M - - - 12.7 M - - - 28.7 M - - - 39 M - - - 1.36 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 17.8 M - - - 3.22 M - - - - - - - 35 M - - - 33.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 17.8 M - - - 3.22 M - - - 24.8 M - - - 35 M - - - 33.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency